Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17557
Title: Injectable eggshell-derived hydroxyapatite-incorporated fibroin-alginate composite hydrogel for bone tissue engineering
Authors: Chuysinuan P.
Nooeaid P.
Thanyacharoen T.
Techasakul S.
Pavasant P.
Kanjanamekanant K.
Keywords: alginic acid
biomaterial
fibroin
hydroxyapatite
animal
cell line
chemistry
egg shell
hydrogel
mouse
pharmacology
procedures
tissue engineering
tissue scaffold
Alginates
Animals
Biocompatible Materials
Cell Line
Durapatite
Egg Shell
Fibroins
Hydrogels
Mice
Tissue Engineering
Tissue Scaffolds
Issue Date: 2021
Abstract: Tissue engineering is a promising approach to repair and regenerate damaged or lost tissues or organs. In dental aspect, reconstruction of the resorbed alveolar bone after tooth extraction plays an important role in the success of dental substitution, especially in dental implant treatment. The hydroxyapatite (HA)-incorporated fibroin-alginate composite injectable hydrogel was fabricated to be used as scaffold for bone regeneration. HA was synthesized from eggshell biowaste. Fibroin was extracted from Bombyx mori cocoon. The synthesized HA, fibroin and alginate hydrogel were characterized. HA-incorporated fibroin-alginate hydrogel had decreased pore size and porosity compared with pure alginate hydrogel. Thermal analysis showed that hydrogel had a degradation peak of approximately 250 °C. Hydrogel could absorb water, with a swelling ratio of around 300% at 24 h. Hydrogel was degraded as time passed and almost completely degraded at day 7. Its compressive Young's modulus was approximately 0.04 ± 0.02 N/mm2 to 0.10 ± 0.02 N/mm2. Primary cytotoxicity test indicated non-toxic potential of the fabricated hydrogel. Increased ALP activity was observed in MC3T3-E1 cultured in HA-incorporated fibroin-alginate hydrogel. Results suggested the potential use of injectable HA fibroin-alginate hydrogel as dental scaffolding material. Further studies including in vivo examinations are needed prior to its clinical application. © 2021 Elsevier B.V.
URI: https://ir.swu.ac.th/jspui/handle/123456789/17557
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118486327&doi=10.1016%2fj.ijbiomac.2021.10.132&partnerID=40&md5=14c08abc2693f472ff8513ff3886a313
ISSN: 1418130
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.